Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 2/20 | 0.49 |
| ▸ | CACNA1C | Q13936 | 3/20 | 0.43 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.43 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.43 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13587769 | 0.95 | NR3C2 (0.46) | NR3C2CACNA1CCACNA1FCACNA1DCACNA1S | |
| SCHEMBL13587810 | 0.95 | NR3C2 (0.50) | NR3C2CACNA1CCACNA1FCACNA1DCACNA1S | |
| SCHEMBL13587798 | 0.95 | NR3C2 (0.47) | NR3C2CACNA1CCACNA1FCACNA1DCACNA1S | |
| SCHEMBL13587751 | 0.93 | NR3C2 (0.47) | NR3C2CACNA1CCACNA1FCACNA1DCACNA1S | |
| SCHEMBL13587753 | 0.88 | NR3C2 (0.46) | NR3C2CACNA1CCACNA1FCACNA1DCACNA1S | |
| SCHEMBL8260711 | 0.86 | NR3C2 (0.62) | NR3C2CACNA1CCACNA1FCACNA1DCACNA1S | |
| SCHEMBL13587742 | 0.84 | NR3C2 (0.58) | NR3C2CACNA1CCACNA1FCACNA1DCACNA1S | |
| SCHEMBL8261160 | 0.83 | NR3C2 (0.50) | NR3C2 | |
| SCHEMBL13587770 | 0.83 | NR3C2 (0.57) | NR3C2CACNA1CCACNA1FCACNA1DCACNA1S | |
| SCHEMBL13587808 | 0.83 | NR3C2 (0.57) | NR3C2CYP1A2CYP3A4ADORA3MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090298872-A1 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES | IRM LLC (BM) | 2009-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090298872-A1 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF STEROIDAL RECEPTORS AND CALCIUM CHANNEL ACTIVITIES | TRPV1, TRPV2, TRPV6 | NR3C2 12/4885CACNA1C 27/4885CACNA1F 34/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.